Consensus $299.9M. Sees FY23 New studio openings in the range of 540 to 560, or an increase of 8% at the midpoint as compared to full year 2022; North America system-wide sales in the range of $1.385 billion to $1.395 billion, or an increase of 35% at the midpoint as compared to full year 2022; this compares to previous guidance of $1.370 billion to $1.380 billion; Adjusted EBITDA in the range of $102.5 million to $106.5 million, or an increase of 41% at the midpoint as compared to full year 2022; this compares to previous guidance of $102.0 million to $106.0 million.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on XPOF:
- Xponential short report ‘distortion of facts and data,’ says B. Riley
- Xponential Fitness ‘effectively addressed’ short’s accusations, says Lake Street
- Citi satisfied with Xponential Fitness response to short report
- XPOF Regains Footing after Wall Street Keeps Growth Thesis Intact
- Xponential Fitness rises 18.4%
